Anna Morena D'Alise

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Vaccines

Cancer immunology research

Nouscom

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nouscom

Italy

Head of Immunology :: Immunology

Publications

Irene Garzia, Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, Simona Allocca, Giuseppina Romano, Laura Conti, Carmen Caiazza, Concetta Ambrosino, Valeria Poli, Elisa Scarselli, Anna Morena D'Alise
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine. Cancer immunology research 12 (4) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Irene Garzia, Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, Simona Allocca, Giuseppina Romano, Laura Conti, Carmen Caiazza, Concetta Ambrosino, Valeria Poli, Elisa Scarselli, Anna Morena D'Alise
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine. Cancer immunology research 12 (4) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Rosa Bartolomeo, Fulvia Troise, Simona Allocca, Giulia Sdruscia, Rosa Vitale, Veronica Bignone, Anna Maria Petrone, Giuseppina Romano, Anna Morena D'Alise, Valentino Ruzza, Irene Garzia, Guido Leoni, Rossella Merone, Francesca Lanzaro, Stefano Colloca, Loredana Siani, Elisa Scarselli, Gabriella Cotugno
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines 12 (3) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rosa Bartolomeo, Fulvia Troise, Simona Allocca, Giulia Sdruscia, Rosa Vitale, Veronica Bignone, Anna Maria Petrone, Giuseppina Romano, Anna Morena D'Alise, Valentino Ruzza, Irene Garzia, Guido Leoni, Rossella Merone, Francesca Lanzaro, Stefano Colloca, Loredana Siani, Elisa Scarselli, Gabriella Cotugno
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines 12 (3) (2024)
Irene Garzia, Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, Simona Allocca, Giuseppina Romano, Laura Conti, Carmen Caiazza, Concetta Ambrosino, Valeria Poli, Elisa Scarselli, Anna Morena D'Alise
Tumor burden dictates the neoantigen features required to generate an effective cancer vaccine. Cancer immunology research (2024)
Rosa Bartolomeo, Fulvia Troise, Simona Allocca, Giulia Sdruscia, Rosa Vitale, Veronica Bignone, Anna Maria Petrone, Giuseppina Romano, Anna Morena D'Alise, Valentino Ruzza, Irene Garzia, Guido Leoni, Rossella Merone, Francesca Lanzaro, Stefano Colloca, Loredana Siani, Elisa Scarselli, Gabriella Cotugno
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines 12 (3) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Laura Seclì, Luigia Infante, Linda Nocchi, Maria De Lucia, Gabriella Cotugno, Guido Leoni, Elisa Micarelli, Irene Garzia, Lidia Avalle, Giulia Sdruscia, Fulvia Troise, Simona Allocca, Giuseppina Romano, Elisa Scarselli, Anna Morena D'Alise
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity. Journal for immunotherapy of cancer 11 (4) (2023)
Laura Seclì, Luigia Infante, Linda Nocchi, Maria De Lucia, Gabriella Cotugno, Guido Leoni, Elisa Micarelli, Irene Garzia, Lidia Avalle, Giulia Sdruscia, Fulvia Troise, Simona Allocca, Giuseppina Romano, Elisa Scarselli, Anna Morena D'Alise
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity. Journal for immunotherapy of cancer 11 (4) (2023)
Laura Seclì, Guido Leoni, Valentino Ruzza, Loredana Siani, Gabriella Cotugno, Elisa Scarselli, Anna Morena D'Alise
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer. International journal of molecular sciences 24 (23) (2023)
Laura Seclì, Luigia Infante, Linda Nocchi, Maria De Lucia, Gabriella Cotugno, Guido Leoni, Elisa Micarelli, Irene Garzia, Lidia Avalle, Giulia Sdruscia, Fulvia Troise, Simona Allocca, Giuseppina Romano, Elisa Scarselli, Anna Morena D'Alise
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity. Journal for immunotherapy of cancer 11 (4) (2023)
Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis, Guido Leoni, Valentina Russo, Francesca Langone, Denis Baev, Elisa Micarelli, Luca Petiti, Simone Picelli, Marwan G Fakih, Dung T Le, Michael James Overman, Anthony Frank Shields, Katrina S Pedersen, Manish A Shah, Sarbajit Mukherjee, Thea Faivre, Patricia Delaite, Elisa Scarselli, Luigia Pace
Adenoviral-based vaccine promotes neoantigen-specific CD8 + T cell stemness and tumor rejection. Science translational medicine 14 (657) (2022)
Chiara Gentile, Arianna Finizio, Guendalina Froechlich, Anna Morena D'Alise, Gabriella Cotugno, Sara Amiranda, Alfredo Nicosia, Elisa Scarselli, Nicola Zambrano, Emanuele Sasso
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance. International journal of molecular sciences 22 (24) (2021)
Anna Morena D'Alise, Guido Leoni, Maria De Lucia, Francesca Langone, Linda Nocchi, Fabio Giovanni Tucci, Elisa Micarelli, Gabriella Cotugno, Fulvia Troise, Irene Garzia, Rosa Vitale, Veronica Bignone, Elena Di Matteo, Rosa Bartolomeo, Deborah H Charych, Armin Lahm, Jonathan Zalevsky, Alfredo Nicosia, Elisa Scarselli
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion. Journal for immunotherapy of cancer 9 (11) (2021)
Ilaria Esposito, Paola Cicconi, Anna Morena D'Alise, Anthony Brown, Marialuisa Esposito, Leo Swadling, Peter Johannes Holst, Maria Rosaria Bassi, Mariano Stornaiuolo, Federica Mori, Ventzislav Vassilev, Wenqin Li, Timothy Donnison, Chiara Gentile, Bethany Turner, Annette von Delft, Mariarosaria Del Sorbo, Federica Barra, Alessandra Maria Contino, Adele Abbate, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Armin Lahm, Fabiana Grazioli, Virginia Ammendola, Loredana Siani, Stefano Colloca, Paul Klenerman, Alfredo Nicosia, Lucy Dorrell, Antonella Folgori, Stefania Capone, Eleanor Barnes, null null
MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans. Science translational medicine 12 (548) (2021)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, Imma Fichera, Maria De Lucia, Lidia Avalle, Rosa Vitale, Adriano Leuzzi, Veronica Bignone, Elena Di Matteo, Fabio Giovanni Tucci, Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade. Nature communications 10 (1) (2019)

Anna Morena D'Alise.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Morena D'Alise